中文名 | 3-氨基-5-苯基噻吩-2-甲酸甲酯 |
---|---|
英文名 | Methyl 3-amino-5-phenylthiophene-2-carboxylate |
中文别名 |
3-氨基-5-苯基-2-噻吩羧酸甲酯
3-氨基-5-苯基噻吩-2-羧酸甲酯 |
英文别名 |
MFCD00068161
Methyl 3-amino-5-phenylthiophene-2-carboxylate 2-Thiophenecarboxylic acid, 3-amino-5-phenyl-, methyl ester Methyl 3-amino-5-phenyl-2-thiophenecarboxylate |
密度 | 1.3±0.1 g/cm3 |
---|---|
沸点 | 442.5±45.0 °C at 760 mmHg |
熔点 | 147 °C |
分子式 | C12H11NO2S |
分子量 | 233.286 |
闪点 | 221.4±28.7 °C |
精确质量 | 233.051056 |
PSA | 80.56000 |
LogP | 3.25 |
外观性状 | 黄色晶体 |
蒸汽压 | 0.0±1.1 mmHg at 25°C |
折射率 | 1.626 |
储存条件 | 密封储存,储存于阴凉、干燥的库房。远离氧化物,碱。 |
稳定性 | 常温常压下稳定,避免与碱,氧化剂接触。 |
分子结构 | 1、摩尔折射率:65.23 2、摩尔体积(cm3/mol):184.3 3、等张比容(90.2K):494.4 4、表面张力(dyne/cm):51.7 5、介电常数:无可用的 6、极化率(10-24cm3):25.86 7、单一同位素质量:233.051049 Da 8、标称质量:233 Da 9、平均质量:233.2862 Da |
计算化学 | 1.疏水参数计算参考值(XlogP):3.3 2.氢键供体数量:1 3.氢键受体数量:4 4.可旋转化学键数量:3 5.互变异构体数量:3 6.拓扑分子极性表面积80.6 7.重原子数量:16 8.表面电荷:0 9.复杂度:253 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
更多 | 1. 性状:白色粉末 2. 密度(g/mL,20℃):未确定 3. 相对蒸汽密度(g/mL,空气=1):未确定 4. 熔点(ºC):145-148 5. 沸点(ºC,常压):未确定 6. 沸点(ºC,1mmHg):未确定 7. 折射率(n20/D):未确定 8. 闪点(ºC):未确定 9. 比旋光度(º):未确定 10. 自燃点或引燃温度(ºC):未确定 11. 蒸气压(mmHg,20ºC):未确定 12. 饱和蒸气压(kPa,25ºC):未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(ºC):未确定 15. 临界压力(KPa):未确定 16. 油水(辛醇/水)分配系数的对数值:未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V):未确定 19. 溶解性:未确定 |
Synonym: Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
Risk Phrases: None Listed. Section 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW
Not available. Potential Health Effects Eye: May cause eye irritation. Skin: May cause skin irritation. May be harmful if absorbed through the skin. Ingestion: May cause irritation of the digestive tract. May be harmful if swallowed. Inhalation: May cause respiratory tract irritation. May be harmful if inhaled. Chronic: Not available. Section 4 - FIRST AID MEASURES Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid. Skin: Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Ingestion: Get medical aid. Wash mouth out with water. Inhalation: Remove from exposure and move to fresh air immediately. Notes to Physician: Treat symptomatically and supportively. Section 5 - FIRE FIGHTING MEASURES General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Extinguishing Media: Use water spray, dry chemical, carbon dioxide, or chemical foam. Section 6 - ACCIDENTAL RELEASE MEASURES General Information: Use proper personal protective equipment as indicated in Section 8. Spills/Leaks: Vacuum or sweep up material and place into a suitable disposal container. Section 7 - HANDLING and STORAGE Handling: Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes. Storage: Store in a cool, dry place. Store in a tightly closed container. Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION Engineering Controls: Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 100063-22-7: Personal Protective Equipment Eyes: Not available. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. Respirators: Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced. Section 9 - PHYSICAL AND CHEMICAL PROPERTIES Physical State: Solid Color: off-white Odor: Not available. pH: Not available. Vapor Pressure: Not available. Viscosity: Not available. Boiling Point: Not available. Freezing/Melting Point: 145 - 148 deg C Autoignition Temperature: Not available. Flash Point: Not available. Explosion Limits, lower: Not available. Explosion Limits, upper: Not available. Decomposition Temperature: Solubility in water: Specific Gravity/Density: Molecular Formula: C12H11NO2S Molecular Weight: 233 Section 10 - STABILITY AND REACTIVITY Chemical Stability: Not available. Conditions to Avoid: Incompatible materials. Incompatibilities with Other Materials: Strong oxidizing agents, acid chlorides. Hazardous Decomposition Products: Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide. Hazardous Polymerization: Has not been reported Section 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 100063-22-7 unlisted. LD50/LC50: Not available. Carcinogenicity: Methyl 3-amino-5-phenylthiophene-2-carboxylate - Not listed by ACGIH, IARC, or NTP. Section 12 - ECOLOGICAL INFORMATION Section 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations. Section 14 - TRANSPORT INFORMATION IATA No information available. IMO No information available. RID/ADR No information available. Section 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives Hazard Symbols: Not available. Risk Phrases: Safety Phrases: S 24/25 Avoid contact with skin and eyes. WGK (Water Danger/Protection) CAS# 100063-22-7: No information available. Canada None of the chemicals in this product are listed on the DSL/NDSL list. CAS# 100063-22-7 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 100063-22-7 is not listed on the TSCA inventory. It is for research and development use only. SECTION 16 - ADDITIONAL INFORMATION N/A |
符号 |
GHS07 |
---|---|
信号词 | Warning |
危害声明 | H302 |
危害码 (欧洲) | Xi: Irritant; |
风险声明 (欧洲) | R36/37/38 |
安全声明 (欧洲) | S24/25 |
危险品运输编码 | NONH for all modes of transport |
~50% 100063-22-7 |
文献:LAILA NUTRACEUTICALS Patent: US2010/68178 A1, 2010 ; Location in patent: Page/Page column 14 ; |
~% 100063-22-7 |
文献:Journal of Medicinal Chemistry, , vol. 49, # 24 p. 7095 - 7107 |
~% 100063-22-7 |
文献:Bioorganic and Medicinal Chemistry Letters, , vol. 11, # 1 p. 9 - 12 |
~% 100063-22-7 |
文献:European Journal of Medicinal Chemistry, , vol. 76, p. 343 - 351 |
~% 100063-22-7 |
文献:Bioorganic and Medicinal Chemistry Letters, , vol. 11, # 1 p. 9 - 12 |
~% 100063-22-7 |
文献:European Journal of Medicinal Chemistry, , vol. 65, p. 223 - 231 |